Literature DB >> 22245412

United States national prevalence of electrocardiographic abnormalities in black and white middle-age (45- to 64-Year) and older (≥65-Year) adults (from the Reasons for Geographic and Racial Differences in Stroke Study).

Ronald J Prineas1, Anh Le, Elsayed Z Soliman, Zhu-Ming Zhang, Virginia J Howard, Yechiam Ostchega, George Howard.   

Abstract

A United States national sample of 20,962 participants (57% women, 44% blacks) from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study provided general population estimates for electrocardiographic (ECG) abnormalities among black and white men and women. The participants were recruited from 2003 to 2007 by random selection from a commercially available nationwide list, with oversampling of blacks and those from the stroke belt, with a cooperation rate of 49%. The measurement of risk factors and 12-lead electrocardiograms (centrally coded using Minnesota code criteria) showed 28% had ≥1 major ECG abnormality. The prevalence of abnormalities was greater (≥35%) for those ≥65 years old, with no differences between blacks and whites. However, among men <65 years, blacks had more major abnormalities than whites, most notably for atrial fibrillation, major Q waves, and left ventricular hypertrophy. Men generally had more ECG abnormalities than women. The most common ECG abnormalities were T-wave abnormalities. The average heart rate-corrected QT interval was longer in women than in men, similar in whites and blacks, and increased with age. However, the average heart rate was greater in women than in men and in blacks than in whites and decreased with age. The prevalence of ECG abnormalities was related to the presence of hypertension, diabetes, blood pressure, and age. In conclusion, black men and women in the United States have a significantly greater prevalence of ECG abnormalities than white men and women at age 45 to 64 years; however, these proportions, although larger, tended to equalize or reverse after age 65.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245412      PMCID: PMC3319226          DOI: 10.1016/j.amjcard.2011.11.061

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Prevalence of electrocardiographic abnormalities in a middle-aged, biracial population: Coronary Artery Risk Development in Young Adults study.

Authors:  Joseph A Walsh; Ronald Prineas; Martha L Daviglus; Hongyan Ning; Kiang Liu; Cora E Lewis; Steven Sidney; Pamela J Schreiner; Carlos Iribarren; Donald M Lloyd-Jones
Journal:  J Electrocardiol       Date:  2010-04-05       Impact factor: 1.438

2.  Reporting participation in epidemiologic studies: a survey of practice.

Authors:  Lindsay M Morton; Jack Cahill; Patricia Hartge
Journal:  Am J Epidemiol       Date:  2005-12-07       Impact factor: 4.897

3.  Electrocardiographic reference ranges derived from 79,743 ambulatory subjects.

Authors:  Jay W Mason; Douglas J Ramseth; Dennis O Chanter; Thomas E Moon; Daniel B Goodman; Boaz Mendzelevski
Journal:  J Electrocardiol       Date:  2007-02-05       Impact factor: 1.438

4.  Electrocardiographic findings in a healthy biracial population. Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  L L Vitelli; R S Crow; E Shahar; R G Hutchinson; P M Rautaharju; A R Folsom
Journal:  Am J Cardiol       Date:  1998-02-15       Impact factor: 2.778

5.  Electrocardiographic abnormalities and mortality among middle-aged black men and white men of Evans County, Georgia.

Authors:  D S Strogatz; H A Tyroler; L O Watkins; C G Hames
Journal:  J Chronic Dis       Date:  1987

6.  Electrocardiographic findings in a biracial, urban population. The Birmingham Stroke Study.

Authors:  C P Riley; A Oberman; D C Hurst; P B Peacock
Journal:  Ala J Med Sci       Date:  1973-04

7.  Electrocardiographic findings and incident coronary heart disease among participants in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Daniella B Machado; Richard S Crow; Lori L Boland; Peter J Hannan; Herman A Taylor; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2006-03-09       Impact factor: 2.778

8.  Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants.

Authors:  R J Prineas; C H Castle; J D Curb; R Harrist; A Lewin; J Stamler
Journal:  Hypertension       Date:  1983 Nov-Dec       Impact factor: 10.190

9.  Electrocardiographic abnormalities and 30-year mortality among white and black men of the Charleston Heart Study.

Authors:  S E Sutherland; P C Gazes; J E Keil; G E Gilbert; R G Knapp
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

10.  Comparison of electrocardiographic findings and associated risk factors between Taiwan Chinese and US White adults.

Authors:  Chih-Cheng Wu; Wen-Ting Yeh; Richard S Crow; Chyi-Huey Bai; Wen-Harn Pan
Journal:  Int J Cardiol       Date:  2007-07-25       Impact factor: 4.164

View more
  23 in total

1.  Racial differences in sudden cardiac death.

Authors:  Erin A Fender; Charles A Henrikson; Larisa Tereshchenko
Journal:  J Electrocardiol       Date:  2014-08-01       Impact factor: 1.438

2.  Resting ST amplitude: prognosis and normal values in an ambulatory clinical population.

Authors:  Shirin Zarafshar; Myo Wong; Nikhil Singh; Sonya Aggarwal; Chandana Adhikarla; V F Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-10-23       Impact factor: 1.468

Review 3.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

4.  Major and minor electrocardiographic abnormalities and their association with underlying cardiovascular disease and risk factors in Hispanics/Latinos (from the Hispanic Community Health Study/Study of Latinos).

Authors:  Pablo Denes; Daniel B Garside; Donald Lloyd-Jones; Natalia Gouskova; Elsayed Z Soliman; Robert Ostfeld; Zhu-Ming Zhang; Alvaro Camacho; Ronald Prineas; Leopoldo Raij; Martha L Daviglus
Journal:  Am J Cardiol       Date:  2013-09-19       Impact factor: 2.778

Review 5.  Race, ethnicity, and the risk of sudden death<sup/>.

Authors:  Kyndaron Reinier; Carmen Rusinaru; Sumeet S Chugh
Journal:  Trends Cardiovasc Med       Date:  2018-07-10       Impact factor: 6.677

6.  Electrocardiographic ST-T Abnormities Are Associated With Stroke Risk in the REGARDS Study.

Authors:  Mitsuaki Sawano; Ya Yuan; Shun Kohsaka; Taku Inohara; Takeki Suzuki; Tomonori Okamura; George Howard; Virginia J Howard; Suzanne Judd; Elsayed Z Soliman; Mary Cushman
Journal:  Stroke       Date:  2020-03-04       Impact factor: 7.914

7.  Racial susceptibility for QT prolongation in acute drug overdoses.

Authors:  Alex F Manini; Barry Stimmel; David Vlahov
Journal:  J Electrocardiol       Date:  2013-12-04       Impact factor: 1.438

8.  Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?

Authors:  Kevin Fiscella; Paul C Winters; Michael Mendoza; Gary J Noronha; Carlos M Swanger; John D Bisognano; Robert J Fortuna
Journal:  J Gen Intern Med       Date:  2015-02       Impact factor: 5.128

9.  Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Hemal Bhatt; Christopher M Gamboa; Monika M Safford; Elsayed Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-06-27

10.  Performance of the NINDS-CSN 5-minute protocol in a national population-based sample.

Authors:  Richard E Kennedy; Virginia G Wadley; Leslie A McClure; Abraham J Letter; Frederick W Unverzagt; Michael Crowe; David Nyenhius; Brendan J Kelley; Bhumika Kana; Janice Marceaux; Manjula Kurella Tamura; Virginia Howard; George Howard
Journal:  J Int Neuropsychol Soc       Date:  2014-08-28       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.